Beyond Positive and Negative: Redefining HER2 Testing and Treatment Pathways in Metastatic Breast Cancer
Webinar/Online
Thursday, July 31, 2025 at 2:00pm ET - 3:00pm ET
Add this event to your calendar
Info
Topic
Join us for a dynamic multidisciplinary discussion featuring an expert breast oncologist and pathologist who will share real-world challenges in HER2 testing and interpretation identified through a new nationwide survey of pathologists and compare these with insights from community-based oncologist surveys. Explore best practices for accurate HER2 classification, the latest evidence and guideline recommendations for antibody-drug conjugates in HER2-low and HER2-ultralow advanced breast cancer, and gain expert insights to improve accuracy and workflow efficiency for HER2 testing through enhanced multidisciplinary collaboration.
Credits Offered
This event offers
1.0 contact hour
to attendees.
Accreditation Info:
AANP.
Additional Information
Join us for a dynamic multidisciplinary discussion featuring an expert breast oncologist and pathologist who will share real-world challenges in HER2 testing and interpretation identified through a new nationwide survey of pathologists.
Speakers
Professor of Hematology and Medical Oncology
Co-Director, Breast Medical Oncology
Associate Vice Chair of Faculty Development and Promotions
Winship Cancer Institute at Emory University
Atlanta, GA
Associate Professor of Pathology and Laboratory Medicine
Robert Larner, MD College of Medicine
University of Vermont
Medical Director, Genomic Medicine
University of Vermont Medical Center
Burlington, VT
Clinical Associate Professor, Hematology/Oncology - School of Pharmacy
Associate Professor, Precision Medicine - Graduate School of Biomedical Sciences
The Medical College of Wisconsin
Milwaukee, WI